Legal status · United States
Is SHLP2 legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. SHLP2 is not an approved medicine in the United States; its classification is "Not a medicine; endogenous signalling molecule". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
SHLP2 in the United States at a glance
| Classification | Not a medicine; endogenous signalling molecule |
|---|---|
| Note | An endogenous mitochondrial-derived peptide. No approved drug acts at CXCR7 for this purpose and no SHLP2 product has been evaluated by the FDA. Material sold under this name is a research chemical. |
| FDA approval status | Not approved, not in development as a drug in any public filing, and with no investigational new drug programme located. It is an endogenous peptide that people can measure in plasma, not a product. |
| Human studies cited | 2 of 6 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the SHLP2 profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing SHLP2 is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What SHLP2 is
A mitochondrial-derived peptide with an identified receptor, a mouse obesity result and a human genetic association with protection against Parkinson's disease. It has never been administered to a person, and no trial is registered.
In 2016 a search of the same stretch of mitochondrial 16S ribosomal RNA that encodes humanin turned up six more short open reading frames. Those became SHLP1 through SHLP6, the small humanin-like peptides.
Mechanism: Encoded in the mitochondrial genome, in the 16S rRNA region, and released to act as a signalling peptide. The identified receptor is CXCR7, an atypical chemokine receptor.
Regulatory history: Not approved, not in development as a drug in any public filing, and with no investigational new drug programme located. It is an endogenous peptide that people can measure in plasma, not a product.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for SHLP2 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
SHLP2 in other countries
Frequently asked questions
Is SHLP2 legal in the United States?
No. SHLP2 is not an approved medicine in the United States; its classification is "Not a medicine; endogenous signalling molecule". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile. Note: An endogenous mitochondrial-derived peptide. No approved drug acts at CXCR7 for this purpose and no SHLP2 product has been evaluated by the FDA. Material sold under this name is a research chemical.
Can I buy SHLP2 in the United States?
No approved product exists to buy. In the United States SHLP2 is classified as "Not a medicine; endogenous signalling molecule", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: An endogenous mitochondrial-derived peptide. No approved drug acts at CXCR7 for this purpose and no SHLP2 product has been evaluated by the FDA. Material sold under this name is a research chemical.
Is SHLP2 FDA approved?
No. FDA status: Not approved, not in development as a drug in any public filing, and with no investigational new drug programme located. It is an endogenous peptide that people can measure in plasma, not a product.. Current US classification: "Not a medicine; endogenous signalling molecule". On the evidence, 2 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for SHLP2 live on its compound profile.
SHLP2 profileThis page is general information about the regulatory status of SHLP2 in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.